Starling Oncology reported cash from operations of $11.94M and free cash flow of $11.03M for the quarter ended Jun 2026, up 217.0% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||
| Net Income | -2.98M | -10.16M | 19.29M | -5.45M | -2.67M | -11.01M | -30.00M | -16.90M | -17.42M | -18.75M | -19.89M | -15.48M | -16.11M | -13.18M | -19.59M | -17.01M | -16.50M | -7.51M | -2.49M | -9.79M | ||||||
| Share-based CompensationStock Comp. | 0.06M | 24.38M | 8.55M | 6.51M | 6.55M | 6.07M | 4.96M | 4.11M | 4.66M | 4.08M | 4.09M | 3.39M | 2.39M | 1.29M | 1.46M | 0.75M | 1.02M | 1.32M | 1.69M | 1.07M | ||||||
| Deferred Taxes | -3.76M | 2.30M | 0.18M | -0.05M | 0.05M | -0.45M | -0.03M | -0.00M | 0.08M | -0.13M | ||||||||||||||||
| Gains from Investment SecuritiesGains Investment | -24.89M | -39.44M | -10.80M | -3.58M | -5.39M | -0.75M | -0.12M | 0.20M | -0.01M | -0.55M | -0.02M | -0.05M | 0.04M | 0.05M | 0.15M | 0.00M | -0.17M | -0.01M | ||||||||
| Asset Writedowns and ImpairmentWritedown | 0.06M | 0.25M | 0.15M | 0.10M | 0.14M | 0.07M | 0.00M | -0.00M | 0.03M | 1.99M | -2.40M | |||||||||||||||
| Cash from OperationsCash from Ops. | -2.68M | -23.34M | -16.98M | -10.38M | -20.40M | -14.00M | -15.45M | -8.66M | -8.31M | -3.89M | -15.88M | -15.66M | 0.82M | 4.00M | -4.99M | -10.20M | -12.63M | 3.23M | -2.21M | 11.94M | ||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 0.03M | 0.99M | 0.92M | 0.67M | -0.88M | 1.92M | 0.32M | 0.13M | 0.05M | 0.00M | ||||||||||||||||
| Amortization of Deferred ChargesAmort. Deferred Charges | 0.02M | 0.89M | 1.55M | 1.52M | 1.54M | 1.57M | 1.57M | 1.56M | 1.56M | 1.59M | 1.59M | 4.87M | 1.13M | 1.17M | 1.21M | 1.21M | 1.26M | |||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.85M | 0.92M | 0.99M | 1.10M | 1.13M | 1.19M | 1.27M | 1.33M | 1.70M | 1.58M | 1.49M | 1.52M | 1.57M | 1.71M | 1.78M | 1.80M | 1.72M | 1.63M | 1.62M | 1.84M | ||||||
| Change in Working Capital | ||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | 2.40M | -2.00M | 4.66M | 4.54M | 6.01M | 5.07M | 6.14M | 0.43M | 2.08M | -4.09M | 16.40M | -4.74M | 0.48M | -6.17M | 0.98M | 7.98M | 3.98M | -0.64M | -0.86M | 8.21M | ||||||
| Change in InventoryChange Inventory | 1.07M | 0.50M | 1.33M | 0.40M | 0.85M | -0.85M | 0.99M | 1.91M | 0.01M | 1.47M | -2.12M | -0.23M | -1.22M | -0.07M | 2.27M | 3.48M | 3.10M | -2.01M | 7.42M | -4.28M | ||||||
| Change in Account PayablesChange Payables | 5.30M | -3.33M | -2.96M | 1.30M | -2.75M | -1.78M | 2.57M | 1.18M | 0.21M | 1.10M | 6.36M | -5.46M | 7.58M | 0.74M | 5.06M | 6.43M | 0.44M | 7.71M | 4.61M | 12.50M | ||||||
| Change in Accured ExpensesChange Accured Exp. | -0.06M | -4.52M | 0.53M | 2.04M | 0.33M | -0.55M | -0.81M | 2.15M | -0.77M | 2.78M | 5.37M | -3.39M | 2.84M | 4.66M | 2.57M | -0.30M | 0.13M | -2.84M | 3.92M | 3.44M | ||||||
| Change in TaxesChange Taxes | 4.38M | -6.03M | 0.26M | -0.13M | -0.00M | -0.26M | ||||||||||||||||||||
| Other Working Capital ChangesOther WC Changes | 3.01M | |||||||||||||||||||||||||
| Investing Activities | ||||||||||||||||||||||||||
| Capital ExpendituresCapex | 0.95M | 0.87M | 1.00M | 1.34M | 1.19M | 2.00M | 1.84M | 0.94M | 0.93M | 0.86M | 0.61M | 1.83M | -0.40M | 1.75M | 0.33M | 1.21M | 0.60M | 1.06M | 1.04M | 0.91M | ||||||
| Sales of Property, Plant and EquipmentPP&E (Sale) | 0.13M | |||||||||||||||||||||||||
| Acquisitions | 8.28M | 8.92M | -0.81M | 0.47M | 0.16M | |||||||||||||||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 30.00M | 30.13M | 8.57M | 12.56M | 20.00M | 20.00M | 10.00M | |||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | -0.95M | -9.15M | -1.00M | -10.26M | -87.78M | -32.57M | 18.40M | 24.90M | 7.71M | 11.63M | 19.39M | 18.18M | 10.40M | -1.75M | -0.20M | -1.21M | -0.60M | -1.06M | -1.04M | -0.91M | ||||||
| Financing Activities | ||||||||||||||||||||||||||
| Other financing activitiesOther financing | 0.07M | 15.36M | 0.02M | 0.09M | ||||||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | -0.01M | 136.13M | -1.66M | -10.69M | 105.39M | -0.85M | -1.71M | -2.60M | -0.76M | -1.78M | -0.94M | -2.15M | -0.24M | -0.16M | -4.74M | 1.96M | 10.60M | 3.73M | -0.03M | -0.22M | ||||||
| Change in Capital Stock | ||||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 0.08M | 0.01M | 0.11M | 0.07M | 0.00M | -0.07M | 0.14M | 2.20M | 11.80M | 3.89M | ||||||||||||||||
| Additional items | ||||||||||||||||||||||||||
| Change in Cash | -3.64M | 103.64M | -19.64M | -31.33M | -2.78M | -47.41M | 1.24M | 13.64M | -1.36M | 5.95M | 2.57M | 0.37M | 10.98M | 2.27M | -9.93M | -9.45M | -2.63M | 5.91M | -3.29M | 10.81M | ||||||
| Free Cash FlowFCF | -3.63M | -24.21M | -17.98M | -11.72M | -21.59M | -15.99M | -17.29M | -9.60M | -9.24M | -4.75M | -16.49M | -17.49M | 1.22M | 2.25M | -5.32M | -11.41M | -13.23M | 2.17M | -3.26M | 11.03M | ||||||
| Net Cash FlowNCF | -3.64M | 103.64M | -19.64M | -31.33M | -2.78M | -47.41M | 1.24M | 13.64M | -1.36M | 5.95M | 2.57M | 0.37M | 10.98M | 2.08M | -9.93M | -9.45M | -2.63M | 5.91M | -3.29M | 10.81M |